NDC 24856-002

JETREA

Ocriplasmin

JETREA is a Intravitreal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Thrombogenics Inc.. The primary component is Ocriplasmin.

• Product ID: 24856-002_9bec9cc5-68b7-4a90-b540-68953796cb7e
• NDC: 24856-002
• Product Type: Human Prescription Drug
• Proprietary Name: JETREA
• Generic Name: Ocriplasmin
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVITREAL
• Marketing Start Date: 2017-09-18
• Marketing Category: BLA / BLA
• Application Number: BLA125422
• Labeler Name: ThromboGenics Inc.
• Substance Name: OCRIPLASMIN
• Active Ingredient Strength: 1 mg/mL
• Pharm Classes: Proteolytic Enzyme [EPC],Peptide Hydrolases [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 24856-002-01

1 VIAL, SINGLE-USE in 1 CARTON (24856-002-01) > .3 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 2017-09-18
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 24856-002-01 [24856000201]

JETREA INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA125422
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2017-09-18

Drug Details

Active Ingredients

Ingredient	Strength
OCRIPLASMIN	1.25 mg/mL

OpenFDA Data

• SPL SET ID: fe91cb6f-c77b-4a9f-9df5-a413cd5dbbd7
• Manufacturer:
  • ThromboGenics Inc.
• UNII:
  • 7V6HE3DM5A
• RxNorm Concept Unique ID - RxCUI:
  • 1944947
  • 1944949

Pharmacological Class

• Proteolytic Enzyme [EPC]
• Peptide Hydrolases [CS]